122 related articles for article (PubMed ID: 11904294)
1. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells.
Tang T; Arbiser JL; Brandt SJ
J Biol Chem; 2002 May; 277(21):18365-72. PubMed ID: 11904294
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.
Tang T; Prasad KS; Koury MJ; Brandt SJ
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):615-20. PubMed ID: 10527940
[TBL] [Abstract][Full Text] [Related]
3. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein.
Prasad KS; Brandt SJ
J Biol Chem; 1997 Apr; 272(17):11457-62. PubMed ID: 9111058
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.
Cheng JT; Cobb MH; Baer R
Mol Cell Biol; 1993 Feb; 13(2):801-8. PubMed ID: 8423803
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
Nie L; Wu H; Sun XH
J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
[TBL] [Abstract][Full Text] [Related]
7. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
8. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.
Park C; Afrikanova I; Chung YS; Zhang WJ; Arentson E; Fong Gh Gh; Rosendahl A; Choi K
Development; 2004 Jun; 131(11):2749-62. PubMed ID: 15148304
[TBL] [Abstract][Full Text] [Related]
9. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
[TBL] [Abstract][Full Text] [Related]
10. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
Hansson A; Manetopoulos C; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
[TBL] [Abstract][Full Text] [Related]
11. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
Wadman IA; Hsu HL; Cobb MH; Baer R
Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
[TBL] [Abstract][Full Text] [Related]
12. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.
Drake CJ; Brandt SJ; Trusk TC; Little CD
Dev Biol; 1997 Dec; 192(1):17-30. PubMed ID: 9405094
[TBL] [Abstract][Full Text] [Related]
13. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL.
Huang S; Qiu Y; Shi Y; Xu Z; Brandt SJ
EMBO J; 2000 Dec; 19(24):6792-803. PubMed ID: 11118214
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation.
Terme JM; Lhermitte L; Asnafi V; Jalinot P
Blood; 2009 Jun; 113(26):6695-8. PubMed ID: 19406989
[TBL] [Abstract][Full Text] [Related]
15. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
16. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
17. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
[TBL] [Abstract][Full Text] [Related]
18. Tal1/SCL binding to pericentromeric DNA represses transcription.
Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
[TBL] [Abstract][Full Text] [Related]
19. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
Huang S; Brandt SJ
Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
